SlideShare a Scribd company logo
1 of 21
Using financial incentives to
increase testing uptake and
reduce risk behavior in men
Jennie van de Weerd
18 January 2011
Overview of presentation
 The problem
 The intervention
 Objectives
 Literature review
 Costing model
 Discussion
The problem
 For every 2 HIV+ people put on treatment, another 5
are getting infected. This calls for innovative ways to
prevent HIV transmission and stop the epidemic
 STIs accounted for more than 26% of all deaths and
over 5 million DALYs in 2000 in RSA. Over 98% of
this burden was due to HIV/AIDS.
 African males between 25-49 have been identified
as a RSA specific MARP with HIV+ at 27.3%,
declining comprehensive knowledge and low HIV
testing levels.
The problem
 Testing HIV+ has a significant effect on
reducing risk behavior. Effect of testing HIV-
is less pronounced.
 The Cost Effectiveness of HIV-testing has
been proven in several studies.
 New HIV testing models (PIT, UT, mobile)
still necessitate first step by tester. This is
difficult in areas and populations where
stigma is high.
The intervention – IY / DTHF / MSR
 Desmund Tutu HIV foundation reaches out to hard to reach
populations in informal settlements around Cape Town with the
Tutu-tester.Testing is free and integrated in health check to
reduce stigma
 Incentive of ZAR 75/- is offered by Indlu Yegazi to daily labourers
(on special days when Tutu tester is near Men-on-the-Side-of-
the-Road site).
 MSR have low testing levels and high HIV+. Incentive is paid
irrespective of testing result.
 When testing HIV-, test can be repeated after 6 months.
Incentive is intended to motivate MSR to stay negative during
this period.
 HIV+ are referred to treatment program of DTHF
Objectives
Aim:
Explore whether providing incentive based HIV-
testing for men could be an effective way of HIV-
prevention
Objectives:
1. Literature review on the use of incentive-based
systems to increase uptake of preventive services
and change behaviour with a focus on HIV-testing
2. Assess the potential cost-effectivenees of
incentive provision for HIV-testing and behaviour
change in South Africa
Use of incentive-based systems to
increase uptake of preventive
services and change behaviour with a
focus on HIV-testing
Literature review
Specific objectives literature review
 Which theories exist to explain the motivation and
determinants for men to take up HIV-testing and
change behaviour?
 What are determinants for HIV-testing uptake in
South Africa?
 Which examples exist of increases in uptake of
services, strengthened adherence to treatment or
changed behaviour due t o the use of material
incentives?
 What are the ethics of providing a financial incentive
(to a specific group)?
Theories: Motivation!
 Behavioural economics: opportunity cost,
time-preference, rationality (maximizer)
 Communication theory: therapeutic alliance
 Cognitive dissoncance theory
HIV Prevention
Information
HIV Prevention
Motivation
HIV Prevention
Behavioral Skills
HIV Preventive
Behavior
IMB-model with stigma as environmental factor.
Determinants for testing uptake in men
 Costs and access to HIV-testing
Physical access and willingness and ability to absorb monetary and time-
related costs to go for a test
 Stigma
Family based stigma less a problem for men, though fear to loose position in
the community.
 Risk perception
Low risk perception and HIV is only one of the threats faced, most of which
are considered more pressing and immediate.
 Motivation to test
High opportunity costs, high stigma and low risk perception result in low
motivation to test. Correct knowledge is low (positively related with being
tested)
Lessons learned from other interventions
Contingency management:
The systematic reinforcement of desired behaviour and
the withholding of reinforcement or punishmeent of
undesired behavour. Conditional Cash Transfer
programs are considered to fall under this definition.
•51 articles included referring to 49 studies;
•9 reviews referring to 235 studies
•Only 2 studies were done in Africa
•15 referred to HIV preventive behaviour
•CM mainly used in sustance abuse (drug, alcohol, smoking)
related high risk populations.
•WB finished proof of concept study in Malawi and Tanzania
Lessons learned(cont.)
 Simple or complex target behaviour?
 Target population
 Choice of incentive
 Incentive size
 Incentive provision: frequency and timing
 Incentive duration
Ethical considerations
 At population level: Paying an incentive from
public health or economic efficiency point of
view to create positive externalities (for HIV
testing: better treatment results, reduction in
rate of HIV transmission)
 At individual level: autonomy and informed
uptake. Height of incentive and way testing is
provided will determing whether this can be
guaranteed
Assess the potential cost-effectiveness
of incentive provision for HIV-testing
and behaviour change in South Africa
Costing model
Specific objectives costing model
 What is the additional cost of providing an incentive
per HIA over a 5-year period to a cohort of men?
 What is the potential cost saving per HIA over a five-
year period to a cohort of men?
 What is the necessary reduction in the chance of
getting infected with HIV and the necessary time-
span to justify the current provision of an incentive?
 How are the outcomes of the calculation model
influenced by different values of the key variables
(sensitivity analysis)?
Costing model
Motivated to test = n
HIV+
HIV-
On ART treatment
Not on ART treatment
Lost to follow up
Men on the side of the Road
(MSR)
Men on the side of the Road
(MSR)
1-nl
p
1-p
nl
t
1-t
IncentiveI
Model parameters
[1]
Current situation
(control)[2]
Incentive effect
Chance to become
infected (p)
0.20 0.15, 0.10, 0.05,
0.00
Incentive value (I) 0 10.22 US$
Number of testers
(n)
3696 4416[3]
Number of tests (nt) 2 2
Loss to follow up
(nl)[4]
0.15 0.00, 0.05, 0.10
[1] All parameters in the model can be changed.
[2] Based on the M&E 2009 data for MSR
[3] In 2009, utilisation rate was 77% of full capacity per day (40 testers) without incentive and 92% with incentive
[4] No data could be retrieved from DTHF/IY. Rutledge et al, 2002 found average attrition over 12 sexually transmitted HIV prevention interventions based
Number of men tested and HIA
-500
0
500
1.000
1.500
2.000
2.500
1 2 3 4 5
Testers p(i)=0,15
Testers p(i)=0,00
HIA with p(i)=0.15
HIA with p(i)=0.00
Extra HIV+ with
p(i)=0.15
Uptake of testing will be higher and loss to follow up lower, therefore more
HIV+. Thus HIA can even be negative (yellow line).
Cost of incentive provision
0
500
1.000
1.500
2.000
2.500
3.000
3.500
4.000
4.500
5.000
1 2 3 4 5
Year
US$
HIA nl(i) = 0.10
p(i)=0.10
HIA nl(i) = 0.10 Disc.
p(i)=0.10
HIA nl(i) = 0.00
p(i)=0.10
HIA nl(i) = 0.00 Disc.
p(i)=0.10
Cost of incentive per HIA increases after 2 years, more so for a
lower loss to follow up and bigger reductions of the chance to get
infected (since more testers mean more incentive costs).
Potential cost saving
 Potential cost saving per
HIA slowly increases over
time
 Cost saving is negative for
p=0.15 over 2 years
regardless of level of loss to
follow up.
 Average cost saving evens
out with different nl and p
but number of HIA differs
(thus indirect infections and
costs)
Potential cost savings per HIA with different loss
to follow up over 2 years
-10000
-5000
0
5000
nl(i)=0.10 nl(i)=0.05 nl(i)=0.00
Chance to get infected intervention group
CostperHIAinUS$
p=0.15
p=0.10
p=0.05
p=0.00
Potential cost savings per HIA with different loss
to follow up over 5 years
0
2000
4000
6000
8000
nl(i)=0.10 nl(i)=0.05 nl(i)=0.00
Chance to get infected intervention group
CostperHIAinUS$ p=0.15
p=0.10
p=0.05
p=0.00
One-way sensitivity analysis
0
200
400
600
800
1000
1200
1400
1600
p(i)=0.10 p(i)=0.05 p(i)=0.00
Different chances of infection
Averagecostofincentiveper
HIAUS$
Base situation
n=4800
Incentive US$16.32
4 tests
Model is responsive to change and reacts as expected.
Conclusions and recommendations
 Incentives will reduce the opportunity costs for testing and
appeals to most important role of men (breadwinner)
 After testing enrolment, engaging men will be important since it is
the incentive which make men enroll, not the intention to change.
 DTHF/IY ensures informed uptake through counselling. Payment
of incentive depends on the test not on the result (autonomy).
 Incentive provision seems to be most cost-effective after 2 years.
Chance to get infected has to be reduced to less than 15%.
 There is room to increase value and/or frequency of incentive
without affecting the CE of incentive provision.
 Incentive provision alone will not change behaviour. There is
need for intense folllow up and behavioural interventions (IMB
mobel) to sustain complex behaviour change.

More Related Content

What's hot

DissertatinDefenseApril142011_original
DissertatinDefenseApril142011_originalDissertatinDefenseApril142011_original
DissertatinDefenseApril142011_originalChris Ferris, PhD
 
Getting evidence from economic evaluation into healthcare practice
Getting evidence from economic evaluation into healthcare practiceGetting evidence from economic evaluation into healthcare practice
Getting evidence from economic evaluation into healthcare practicecheweb1
 
How a 5 Hospital System Reduced Infection Rates, Saved Over $2 million and In...
How a 5 Hospital System Reduced Infection Rates, Saved Over $2 million and In...How a 5 Hospital System Reduced Infection Rates, Saved Over $2 million and In...
How a 5 Hospital System Reduced Infection Rates, Saved Over $2 million and In...Innovations2Solutions
 
capstone telephone rx compliance
capstone telephone rx compliancecapstone telephone rx compliance
capstone telephone rx complianceGary Allen
 
LCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLELCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLETony Fanelli
 
Health technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMERHealth technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMERYogesh Arora
 
Heather Dawe: Applications of risk estimation
Heather Dawe: Applications of risk estimationHeather Dawe: Applications of risk estimation
Heather Dawe: Applications of risk estimationNuffield Trust
 
Population Health Management - Angus McCann
Population Health Management - Angus McCannPopulation Health Management - Angus McCann
Population Health Management - Angus McCannNapier University
 
Rodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReadyRodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReadyKate Lee, MPH
 
humanastatinarticle
humanastatinarticlehumanastatinarticle
humanastatinarticlenewtonsapple
 
MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015NHS England
 
Recent Advances in Evidence Based Public Health Practice
Recent Advances in Evidence Based Public Health PracticeRecent Advances in Evidence Based Public Health Practice
Recent Advances in Evidence Based Public Health PracticePrabesh Ghimire
 
An introduction to using cost-effectiveness analysis to inform spending decis...
An introduction to using cost-effectiveness analysis to inform spending decis...An introduction to using cost-effectiveness analysis to inform spending decis...
An introduction to using cost-effectiveness analysis to inform spending decis...Carmen Figueroa
 
Cost-effectiveness of an early awareness campaign for colorectal cancer
Cost-effectiveness of an early awareness campaign for colorectal cancerCost-effectiveness of an early awareness campaign for colorectal cancer
Cost-effectiveness of an early awareness campaign for colorectal cancerEEPRU
 
The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015Cheryl Johnson
 
Harvard Internal Medicine-Pediatrics Noon Conference Feb 3, 2011
Harvard Internal Medicine-Pediatrics Noon Conference Feb 3, 2011Harvard Internal Medicine-Pediatrics Noon Conference Feb 3, 2011
Harvard Internal Medicine-Pediatrics Noon Conference Feb 3, 2011nyayahealth
 

What's hot (19)

DissertatinDefenseApril142011_original
DissertatinDefenseApril142011_originalDissertatinDefenseApril142011_original
DissertatinDefenseApril142011_original
 
Getting evidence from economic evaluation into healthcare practice
Getting evidence from economic evaluation into healthcare practiceGetting evidence from economic evaluation into healthcare practice
Getting evidence from economic evaluation into healthcare practice
 
HIV self-testing
HIV self-testingHIV self-testing
HIV self-testing
 
How a 5 Hospital System Reduced Infection Rates, Saved Over $2 million and In...
How a 5 Hospital System Reduced Infection Rates, Saved Over $2 million and In...How a 5 Hospital System Reduced Infection Rates, Saved Over $2 million and In...
How a 5 Hospital System Reduced Infection Rates, Saved Over $2 million and In...
 
capstone telephone rx compliance
capstone telephone rx compliancecapstone telephone rx compliance
capstone telephone rx compliance
 
LCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLELCA_PRESENTATION_EXAMPLE
LCA_PRESENTATION_EXAMPLE
 
Health technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMERHealth technology assessment- Dr. Saraswathy MD, PGIMER
Health technology assessment- Dr. Saraswathy MD, PGIMER
 
Heather Dawe: Applications of risk estimation
Heather Dawe: Applications of risk estimationHeather Dawe: Applications of risk estimation
Heather Dawe: Applications of risk estimation
 
Population Health Management - Angus McCann
Population Health Management - Angus McCannPopulation Health Management - Angus McCann
Population Health Management - Angus McCann
 
Rodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReadyRodriguez COGEN 90cmX120cm-PrintReady
Rodriguez COGEN 90cmX120cm-PrintReady
 
humanastatinarticle
humanastatinarticlehumanastatinarticle
humanastatinarticle
 
MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015MicroGuide app, pop up uni, 1pm, 3 september 2015
MicroGuide app, pop up uni, 1pm, 3 september 2015
 
Thailand's strategic use of ARV meeting report
Thailand's strategic use of ARV meeting reportThailand's strategic use of ARV meeting report
Thailand's strategic use of ARV meeting report
 
Recent Advances in Evidence Based Public Health Practice
Recent Advances in Evidence Based Public Health PracticeRecent Advances in Evidence Based Public Health Practice
Recent Advances in Evidence Based Public Health Practice
 
An introduction to using cost-effectiveness analysis to inform spending decis...
An introduction to using cost-effectiveness analysis to inform spending decis...An introduction to using cost-effectiveness analysis to inform spending decis...
An introduction to using cost-effectiveness analysis to inform spending decis...
 
Cost-effectiveness of an early awareness campaign for colorectal cancer
Cost-effectiveness of an early awareness campaign for colorectal cancerCost-effectiveness of an early awareness campaign for colorectal cancer
Cost-effectiveness of an early awareness campaign for colorectal cancer
 
The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015The Kenya HIV Testing Services Guidelines 2015
The Kenya HIV Testing Services Guidelines 2015
 
Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatiti...
Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatiti...Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatiti...
Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatiti...
 
Harvard Internal Medicine-Pediatrics Noon Conference Feb 3, 2011
Harvard Internal Medicine-Pediatrics Noon Conference Feb 3, 2011Harvard Internal Medicine-Pediatrics Noon Conference Feb 3, 2011
Harvard Internal Medicine-Pediatrics Noon Conference Feb 3, 2011
 

Viewers also liked (15)

Web 2
Web 2Web 2
Web 2
 
Hidrate spark II FMK 2016-17 Grupo 4
Hidrate spark II FMK 2016-17 Grupo 4 Hidrate spark II FMK 2016-17 Grupo 4
Hidrate spark II FMK 2016-17 Grupo 4
 
Lineas de transmisión
Lineas de transmisiónLineas de transmisión
Lineas de transmisión
 
самостійнаWord комплексна
самостійнаWord комплекснасамостійнаWord комплексна
самостійнаWord комплексна
 
U2 a1 organización y coordinación de equipos de trabajo.
U2 a1 organización y coordinación de equipos de trabajo.U2 a1 organización y coordinación de equipos de trabajo.
U2 a1 organización y coordinación de equipos de trabajo.
 
0620 w10 qp_31
0620 w10 qp_310620 w10 qp_31
0620 w10 qp_31
 
Alergia em Anestesia
Alergia em AnestesiaAlergia em Anestesia
Alergia em Anestesia
 
0610 w10 qp_31
0610 w10 qp_310610 w10 qp_31
0610 w10 qp_31
 
Diagramas de flujo
Diagramas de flujoDiagramas de flujo
Diagramas de flujo
 
Instilaciones vesicales
Instilaciones vesicalesInstilaciones vesicales
Instilaciones vesicales
 
Histologia 2
 Histologia 2 Histologia 2
Histologia 2
 
Silicosis
SilicosisSilicosis
Silicosis
 
Aspectos críticos en un proyecto de investigación clínica. Consideraciones al...
Aspectos críticos en un proyecto de investigación clínica. Consideraciones al...Aspectos críticos en un proyecto de investigación clínica. Consideraciones al...
Aspectos críticos en un proyecto de investigación clínica. Consideraciones al...
 
Tuberculosis pulmonar
Tuberculosis pulmonarTuberculosis pulmonar
Tuberculosis pulmonar
 
Jaramillo trabajo internet
Jaramillo trabajo internetJaramillo trabajo internet
Jaramillo trabajo internet
 

Similar to Using financial incentives to increase testing uptake versie 2

Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"HopkinsCFAR
 
COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...
COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...
COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...COUNTDOWN on NTDs
 
EPIDEMIOLOGY OF PERIODONTAL DISEASE DR SINDHURA.ppt
EPIDEMIOLOGY OF PERIODONTAL DISEASE DR SINDHURA.pptEPIDEMIOLOGY OF PERIODONTAL DISEASE DR SINDHURA.ppt
EPIDEMIOLOGY OF PERIODONTAL DISEASE DR SINDHURA.pptDentalYoutube
 
2015 indicator reference guide priority pop prevention services
2015 indicator reference guide   priority pop prevention services2015 indicator reference guide   priority pop prevention services
2015 indicator reference guide priority pop prevention services#GOMOJO, INC.
 
Hiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi SarkarHiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi Sarkarmrikara185
 
2016 indicator reference guide priority pop prevention services
2016 indicator reference guide   priority pop prevention services2016 indicator reference guide   priority pop prevention services
2016 indicator reference guide priority pop prevention services#GOMOJO, INC.
 
Using modelling to inform our diagnostics strategy
Using modelling to inform our diagnostics strategyUsing modelling to inform our diagnostics strategy
Using modelling to inform our diagnostics strategyUNITAID
 
A Role for Mathematical Models in Program Science
A Role for Mathematical Models in Program ScienceA Role for Mathematical Models in Program Science
A Role for Mathematical Models in Program Scienceamusten
 
WHOでのお仕事@国際医療福祉大学(2019/12)
WHOでのお仕事@国際医療福祉大学(2019/12)WHOでのお仕事@国際医療福祉大学(2019/12)
WHOでのお仕事@国際医療福祉大学(2019/12)Taketo Tanaka
 
Surveillance of healthcare-associated infections: understanding and utilizing...
Surveillance of healthcare-associated infections: understanding and utilizing...Surveillance of healthcare-associated infections: understanding and utilizing...
Surveillance of healthcare-associated infections: understanding and utilizing...Evangelos Kritsotakis
 
2 tool to estimate patient costs literature review_final
2 tool to estimate patient costs literature review_final2 tool to estimate patient costs literature review_final
2 tool to estimate patient costs literature review_finalAira Bhabe
 
Dr. Marion A. Kainer - Antimicrobial Stewardship - the State Health Departmen...
Dr. Marion A. Kainer - Antimicrobial Stewardship - the State Health Departmen...Dr. Marion A. Kainer - Antimicrobial Stewardship - the State Health Departmen...
Dr. Marion A. Kainer - Antimicrobial Stewardship - the State Health Departmen...John Blue
 
Γιώτα Τουλούμη, 6th Clinical Research Conference
Γιώτα Τουλούμη, 6th Clinical Research ConferenceΓιώτα Τουλούμη, 6th Clinical Research Conference
Γιώτα Τουλούμη, 6th Clinical Research ConferenceStarttech Ventures
 
Andhra Pradesh Priorities: Tuberculosis - Arinaminpathy
Andhra Pradesh Priorities: Tuberculosis - ArinaminpathyAndhra Pradesh Priorities: Tuberculosis - Arinaminpathy
Andhra Pradesh Priorities: Tuberculosis - ArinaminpathyCopenhagen_Consensus
 

Similar to Using financial incentives to increase testing uptake versie 2 (20)

Imjh april-2015-5
Imjh april-2015-5Imjh april-2015-5
Imjh april-2015-5
 
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
Anton Pozniak: "The Test and Treat Approach: Achieving 90-90-90"
 
COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...
COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...
COUNTDOWN on WHO 2020 Targets: Strengthening Health Systems Interventions for...
 
EPIDEMIOLOGY OF PERIODONTAL DISEASE DR SINDHURA.ppt
EPIDEMIOLOGY OF PERIODONTAL DISEASE DR SINDHURA.pptEPIDEMIOLOGY OF PERIODONTAL DISEASE DR SINDHURA.ppt
EPIDEMIOLOGY OF PERIODONTAL DISEASE DR SINDHURA.ppt
 
2015 indicator reference guide priority pop prevention services
2015 indicator reference guide   priority pop prevention services2015 indicator reference guide   priority pop prevention services
2015 indicator reference guide priority pop prevention services
 
Hiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi SarkarHiv &ictc seminar by Dr. Mousumi Sarkar
Hiv &ictc seminar by Dr. Mousumi Sarkar
 
2016 indicator reference guide priority pop prevention services
2016 indicator reference guide   priority pop prevention services2016 indicator reference guide   priority pop prevention services
2016 indicator reference guide priority pop prevention services
 
Gender and Health
Gender and HealthGender and Health
Gender and Health
 
Prevention Continuum
Prevention ContinuumPrevention Continuum
Prevention Continuum
 
Stenberg - HIV
Stenberg - HIVStenberg - HIV
Stenberg - HIV
 
Using modelling to inform our diagnostics strategy
Using modelling to inform our diagnostics strategyUsing modelling to inform our diagnostics strategy
Using modelling to inform our diagnostics strategy
 
A Role for Mathematical Models in Program Science
A Role for Mathematical Models in Program ScienceA Role for Mathematical Models in Program Science
A Role for Mathematical Models in Program Science
 
WHOでのお仕事@国際医療福祉大学(2019/12)
WHOでのお仕事@国際医療福祉大学(2019/12)WHOでのお仕事@国際医療福祉大学(2019/12)
WHOでのお仕事@国際医療福祉大学(2019/12)
 
Surveillance of healthcare-associated infections: understanding and utilizing...
Surveillance of healthcare-associated infections: understanding and utilizing...Surveillance of healthcare-associated infections: understanding and utilizing...
Surveillance of healthcare-associated infections: understanding and utilizing...
 
2 tool to estimate patient costs literature review_final
2 tool to estimate patient costs literature review_final2 tool to estimate patient costs literature review_final
2 tool to estimate patient costs literature review_final
 
Cost Effectiveness Analysis of PMTCT service delivery modalities in Addis Aba...
Cost Effectiveness Analysis of PMTCT service delivery modalities in Addis Aba...Cost Effectiveness Analysis of PMTCT service delivery modalities in Addis Aba...
Cost Effectiveness Analysis of PMTCT service delivery modalities in Addis Aba...
 
Basics of epidemiology
Basics of epidemiologyBasics of epidemiology
Basics of epidemiology
 
Dr. Marion A. Kainer - Antimicrobial Stewardship - the State Health Departmen...
Dr. Marion A. Kainer - Antimicrobial Stewardship - the State Health Departmen...Dr. Marion A. Kainer - Antimicrobial Stewardship - the State Health Departmen...
Dr. Marion A. Kainer - Antimicrobial Stewardship - the State Health Departmen...
 
Γιώτα Τουλούμη, 6th Clinical Research Conference
Γιώτα Τουλούμη, 6th Clinical Research ConferenceΓιώτα Τουλούμη, 6th Clinical Research Conference
Γιώτα Τουλούμη, 6th Clinical Research Conference
 
Andhra Pradesh Priorities: Tuberculosis - Arinaminpathy
Andhra Pradesh Priorities: Tuberculosis - ArinaminpathyAndhra Pradesh Priorities: Tuberculosis - Arinaminpathy
Andhra Pradesh Priorities: Tuberculosis - Arinaminpathy
 

More from Jennie van de Weerd

Rapport contre vérification avril-mai 2015 projet 108050
Rapport contre vérification avril-mai 2015 projet 108050Rapport contre vérification avril-mai 2015 projet 108050
Rapport contre vérification avril-mai 2015 projet 108050Jennie van de Weerd
 
The district response initiative on HIV AIDS Action Research - National synth...
The district response initiative on HIV AIDS Action Research - National synth...The district response initiative on HIV AIDS Action Research - National synth...
The district response initiative on HIV AIDS Action Research - National synth...Jennie van de Weerd
 
van de Weerd J 1995 Evaluatie doorstroomprogramma Huishoud en Consumentenwete...
van de Weerd J 1995 Evaluatie doorstroomprogramma Huishoud en Consumentenwete...van de Weerd J 1995 Evaluatie doorstroomprogramma Huishoud en Consumentenwete...
van de Weerd J 1995 Evaluatie doorstroomprogramma Huishoud en Consumentenwete...Jennie van de Weerd
 

More from Jennie van de Weerd (6)

9912 Arsenic prevention sticker
9912 Arsenic prevention sticker9912 Arsenic prevention sticker
9912 Arsenic prevention sticker
 
99 HE message 18DTP
99 HE message 18DTP99 HE message 18DTP
99 HE message 18DTP
 
Rapport contre vérification avril-mai 2015 projet 108050
Rapport contre vérification avril-mai 2015 projet 108050Rapport contre vérification avril-mai 2015 projet 108050
Rapport contre vérification avril-mai 2015 projet 108050
 
MPH van de Weerd 2010
MPH van de Weerd 2010MPH van de Weerd 2010
MPH van de Weerd 2010
 
The district response initiative on HIV AIDS Action Research - National synth...
The district response initiative on HIV AIDS Action Research - National synth...The district response initiative on HIV AIDS Action Research - National synth...
The district response initiative on HIV AIDS Action Research - National synth...
 
van de Weerd J 1995 Evaluatie doorstroomprogramma Huishoud en Consumentenwete...
van de Weerd J 1995 Evaluatie doorstroomprogramma Huishoud en Consumentenwete...van de Weerd J 1995 Evaluatie doorstroomprogramma Huishoud en Consumentenwete...
van de Weerd J 1995 Evaluatie doorstroomprogramma Huishoud en Consumentenwete...
 

Using financial incentives to increase testing uptake versie 2

  • 1. Using financial incentives to increase testing uptake and reduce risk behavior in men Jennie van de Weerd 18 January 2011
  • 2. Overview of presentation  The problem  The intervention  Objectives  Literature review  Costing model  Discussion
  • 3. The problem  For every 2 HIV+ people put on treatment, another 5 are getting infected. This calls for innovative ways to prevent HIV transmission and stop the epidemic  STIs accounted for more than 26% of all deaths and over 5 million DALYs in 2000 in RSA. Over 98% of this burden was due to HIV/AIDS.  African males between 25-49 have been identified as a RSA specific MARP with HIV+ at 27.3%, declining comprehensive knowledge and low HIV testing levels.
  • 4. The problem  Testing HIV+ has a significant effect on reducing risk behavior. Effect of testing HIV- is less pronounced.  The Cost Effectiveness of HIV-testing has been proven in several studies.  New HIV testing models (PIT, UT, mobile) still necessitate first step by tester. This is difficult in areas and populations where stigma is high.
  • 5. The intervention – IY / DTHF / MSR  Desmund Tutu HIV foundation reaches out to hard to reach populations in informal settlements around Cape Town with the Tutu-tester.Testing is free and integrated in health check to reduce stigma  Incentive of ZAR 75/- is offered by Indlu Yegazi to daily labourers (on special days when Tutu tester is near Men-on-the-Side-of- the-Road site).  MSR have low testing levels and high HIV+. Incentive is paid irrespective of testing result.  When testing HIV-, test can be repeated after 6 months. Incentive is intended to motivate MSR to stay negative during this period.  HIV+ are referred to treatment program of DTHF
  • 6. Objectives Aim: Explore whether providing incentive based HIV- testing for men could be an effective way of HIV- prevention Objectives: 1. Literature review on the use of incentive-based systems to increase uptake of preventive services and change behaviour with a focus on HIV-testing 2. Assess the potential cost-effectivenees of incentive provision for HIV-testing and behaviour change in South Africa
  • 7. Use of incentive-based systems to increase uptake of preventive services and change behaviour with a focus on HIV-testing Literature review
  • 8. Specific objectives literature review  Which theories exist to explain the motivation and determinants for men to take up HIV-testing and change behaviour?  What are determinants for HIV-testing uptake in South Africa?  Which examples exist of increases in uptake of services, strengthened adherence to treatment or changed behaviour due t o the use of material incentives?  What are the ethics of providing a financial incentive (to a specific group)?
  • 9. Theories: Motivation!  Behavioural economics: opportunity cost, time-preference, rationality (maximizer)  Communication theory: therapeutic alliance  Cognitive dissoncance theory HIV Prevention Information HIV Prevention Motivation HIV Prevention Behavioral Skills HIV Preventive Behavior IMB-model with stigma as environmental factor.
  • 10. Determinants for testing uptake in men  Costs and access to HIV-testing Physical access and willingness and ability to absorb monetary and time- related costs to go for a test  Stigma Family based stigma less a problem for men, though fear to loose position in the community.  Risk perception Low risk perception and HIV is only one of the threats faced, most of which are considered more pressing and immediate.  Motivation to test High opportunity costs, high stigma and low risk perception result in low motivation to test. Correct knowledge is low (positively related with being tested)
  • 11. Lessons learned from other interventions Contingency management: The systematic reinforcement of desired behaviour and the withholding of reinforcement or punishmeent of undesired behavour. Conditional Cash Transfer programs are considered to fall under this definition. •51 articles included referring to 49 studies; •9 reviews referring to 235 studies •Only 2 studies were done in Africa •15 referred to HIV preventive behaviour •CM mainly used in sustance abuse (drug, alcohol, smoking) related high risk populations. •WB finished proof of concept study in Malawi and Tanzania
  • 12. Lessons learned(cont.)  Simple or complex target behaviour?  Target population  Choice of incentive  Incentive size  Incentive provision: frequency and timing  Incentive duration
  • 13. Ethical considerations  At population level: Paying an incentive from public health or economic efficiency point of view to create positive externalities (for HIV testing: better treatment results, reduction in rate of HIV transmission)  At individual level: autonomy and informed uptake. Height of incentive and way testing is provided will determing whether this can be guaranteed
  • 14. Assess the potential cost-effectiveness of incentive provision for HIV-testing and behaviour change in South Africa Costing model
  • 15. Specific objectives costing model  What is the additional cost of providing an incentive per HIA over a 5-year period to a cohort of men?  What is the potential cost saving per HIA over a five- year period to a cohort of men?  What is the necessary reduction in the chance of getting infected with HIV and the necessary time- span to justify the current provision of an incentive?  How are the outcomes of the calculation model influenced by different values of the key variables (sensitivity analysis)?
  • 16. Costing model Motivated to test = n HIV+ HIV- On ART treatment Not on ART treatment Lost to follow up Men on the side of the Road (MSR) Men on the side of the Road (MSR) 1-nl p 1-p nl t 1-t IncentiveI Model parameters [1] Current situation (control)[2] Incentive effect Chance to become infected (p) 0.20 0.15, 0.10, 0.05, 0.00 Incentive value (I) 0 10.22 US$ Number of testers (n) 3696 4416[3] Number of tests (nt) 2 2 Loss to follow up (nl)[4] 0.15 0.00, 0.05, 0.10 [1] All parameters in the model can be changed. [2] Based on the M&E 2009 data for MSR [3] In 2009, utilisation rate was 77% of full capacity per day (40 testers) without incentive and 92% with incentive [4] No data could be retrieved from DTHF/IY. Rutledge et al, 2002 found average attrition over 12 sexually transmitted HIV prevention interventions based
  • 17. Number of men tested and HIA -500 0 500 1.000 1.500 2.000 2.500 1 2 3 4 5 Testers p(i)=0,15 Testers p(i)=0,00 HIA with p(i)=0.15 HIA with p(i)=0.00 Extra HIV+ with p(i)=0.15 Uptake of testing will be higher and loss to follow up lower, therefore more HIV+. Thus HIA can even be negative (yellow line).
  • 18. Cost of incentive provision 0 500 1.000 1.500 2.000 2.500 3.000 3.500 4.000 4.500 5.000 1 2 3 4 5 Year US$ HIA nl(i) = 0.10 p(i)=0.10 HIA nl(i) = 0.10 Disc. p(i)=0.10 HIA nl(i) = 0.00 p(i)=0.10 HIA nl(i) = 0.00 Disc. p(i)=0.10 Cost of incentive per HIA increases after 2 years, more so for a lower loss to follow up and bigger reductions of the chance to get infected (since more testers mean more incentive costs).
  • 19. Potential cost saving  Potential cost saving per HIA slowly increases over time  Cost saving is negative for p=0.15 over 2 years regardless of level of loss to follow up.  Average cost saving evens out with different nl and p but number of HIA differs (thus indirect infections and costs) Potential cost savings per HIA with different loss to follow up over 2 years -10000 -5000 0 5000 nl(i)=0.10 nl(i)=0.05 nl(i)=0.00 Chance to get infected intervention group CostperHIAinUS$ p=0.15 p=0.10 p=0.05 p=0.00 Potential cost savings per HIA with different loss to follow up over 5 years 0 2000 4000 6000 8000 nl(i)=0.10 nl(i)=0.05 nl(i)=0.00 Chance to get infected intervention group CostperHIAinUS$ p=0.15 p=0.10 p=0.05 p=0.00
  • 20. One-way sensitivity analysis 0 200 400 600 800 1000 1200 1400 1600 p(i)=0.10 p(i)=0.05 p(i)=0.00 Different chances of infection Averagecostofincentiveper HIAUS$ Base situation n=4800 Incentive US$16.32 4 tests Model is responsive to change and reacts as expected.
  • 21. Conclusions and recommendations  Incentives will reduce the opportunity costs for testing and appeals to most important role of men (breadwinner)  After testing enrolment, engaging men will be important since it is the incentive which make men enroll, not the intention to change.  DTHF/IY ensures informed uptake through counselling. Payment of incentive depends on the test not on the result (autonomy).  Incentive provision seems to be most cost-effective after 2 years. Chance to get infected has to be reduced to less than 15%.  There is room to increase value and/or frequency of incentive without affecting the CE of incentive provision.  Incentive provision alone will not change behaviour. There is need for intense folllow up and behavioural interventions (IMB mobel) to sustain complex behaviour change.

Editor's Notes

  1. This is only one slide, but actually has a lot of information. The IMB model states that for effective HIV prevention interventions, you need to work on information, motivation and skills to be effective. If one of the three elements is less developed, this will result in lower or no behaviour change. This model was generalized (validated) for South Africa. Stigma was added as an important environmental factor influencing all elements. Studies have shown that in the short-term this approach to prevention is most effective for men. As explained, stigma influences all elements of the IMB model in South Africa, but motivation to go for testing is severely hindered. Stigma attached to testing increases the opportunity cost of going for testing. A second problem is that people prefer to have a reward now (f.ex. Sex without a condom), than the may-be risk of acquiring HIV in the future (time-preference). Assuming (neo-classical theory) that a man will maximize his utility, he will not go for testing in this situation – a perfectly rational choice. An incentive can reduce the opportunity costs of going for testing (overcome the barrier of stigma), strengthen the time preference (reward is provided immediately) so that it will be rational for the person to go for testing. How long would you need to continue paying? COgnitive dissonance theory suggests that even though initial engagamenet with the program depends on the payment of the incentive, communication with the service providers, enhancement of skills and provision of information can influence motivation so that people as social creatures want to comply with behaviour which is advocated as being good. Communication theory terms this therapeutic alliance and implies that this is sufficient to sustain behaviour.
  2. A study in Eastern Cape found taht every 1 km a man lives away from a tesing facility, reduces the likelihood of going to test. Combined with the lower health centre utilisation of men, PIT might not be the answer to increase testing by men. Mobile testing brings testing facility closer to men but although testing is for free, time spend for testing cannot be spend earning money. Men indicate to prefer to live in doubt than knowing that they are HIV+ (or that the community knows this). Embedding testing in comprehensive health check could address the issue of stigma and acceptability and reduce in higher uptake.
  3. Higher succes rates in simple behaviour (one-off visits) than in complex sustained behaviour change since motivation is external (example of a weight gain study where the incentivized group actually did worse in the long run). Expected that HIV testing will increase but sustained behaviour change will be more difficult. Also, stimulating demand alone is not sufficient, supply of services should be sufficient and of satisfactory quality. The more targetted the intervention (focus on a specific group) the more costly is becomed. Targetting can also induce stigma. Lastly, the incentive will also be paid to people who already behave as expected. So in a way you always pay too much. Is incentive provision necessary ? It is the provider who is paying, but probably another budget who will profit of the cost saving (IY is paying but treatment program of DTHF benefits). Should there be a conditionality (experience shows that when incentives are paid with sufficient income effect people will send their children to school, though adopting highly stigmatized HIV testing is less likely without conditionality. Positive enforcement is nicer for client and provider. In-kind – less liked by clients, cash carries a security risk, vouchers seems to be a safe option. Flat payment, escalating incentive or lottery system (escalating most motivating). Incentive provision alone does not change behaviour – most succesful were those interventions that combined this with attention to the other IMB elements. Determing the exact threshold of incentive height to induce change is difficult and will vary from person to person. Likely that if incentive has only a price effect (on a service which is already not appealing to the client), this will not induce change. Frequency varies from daily to longer term. Reinforcement should be applied as closely as possible to the target behaviour. Frequency and timing are strongly linked to the magnitude of the incentive and the expected behaviour. Incentive is an extrinsic moivator – sustaining behaviour will depend on whether a person has internalized the motivation to behave and the norms in his social networks. Working on Skills and information is therefore important. OPtimal duration of incentive provision will depend on the interplay between all 7 elements.
  4. When incentive is too heigh, men will test no matter what the consequences (and not get information and skills!). When incentive is too low, MSR will not bother to test. This is hardly informed decision making either seen the low level of correct knowledge and high levels of stigma.